Login / Signup

The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson's Disease.

Nicol G M OonkKris L L MovigJob van der PalenHenk-Willem NijmeijerMirjam E van KesterenLucille D A Dorresteijn
Published in: Clinical drug investigation (2021)
Netherlands Trial Register; NL4360.
Keyphrases
  • phase iii
  • study protocol
  • clinical trial
  • phase ii
  • healthcare
  • adverse drug
  • randomized controlled trial
  • emergency department
  • open label
  • electronic health record
  • drug induced